Time to re-evaluate the risks and benefits of valproate and a call for action

Br J Psychiatry. 2022 Dec;221(6):711-713. doi: 10.1192/bjp.2022.94.

Abstract

Valproate is widely used in psychiatry and neurology, including off-label use. Here we consider its potential benefits and risks, particularly for women of childbearing potential, and the evidence that clinical guidelines are adhered to. Finally, we consider the implications for clinical practice and research into its efficacy in off-label indications.

Keywords: anticonvulsants; drug interactions and side-effects; education and training; polypharmacy; psychotic disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticonvulsants* / adverse effects
  • Female
  • Humans
  • Risk Assessment
  • Valproic Acid* / adverse effects

Substances

  • Valproic Acid
  • Anticonvulsants